{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:05:23Z","timestamp":1770296723256,"version":"3.49.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Severe fever with thrombocytopenia syndrome virus (SFTSV) is a tick-borne virus with a human mortality rate of up to 30%, posing a significant threat to public health. However, the lack of suitable research models has impeded the development of effective human vaccines. In this study, we engineered transgenic mice (3xTg) using a novel construct that simultaneously expresses three C-type Lectin receptors, identified as critical SFTSV entry receptors. While this construct substantially enhanced viral binding and infection in BJAB cells, the 3xTg mice exhibited only limited SFTSV replication in the lymph nodes and spleen, without significant impacts on morbidity or mortality. These findings highlight that the overexpression of entry receptors alone is insufficient to fully recapitulate human SFTSV infection in mice. Moreover, our results reveal that the introduction of multiple entry receptors does not necessarily translate to enhanced infection efficacy. This underscores the need for further investigation into the interplay between SFTSV entry mechanisms and host factors to develop more robust mouse models. Advancing such models will be crucial for unraveling the pathogenesis of SFTS pathology and improving strategies for its prevention and treatment in humans.<\/jats:p>","DOI":"10.3389\/fmicb.2024.1452739","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T06:26:00Z","timestamp":1734589560000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Limitations of a proper SFTSV mouse model using human C-type lectin receptors"],"prefix":"10.3389","volume":"15","author":[{"given":"You-Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo-Jin","family":"Ro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaechan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Woong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam-Hyuk","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(22)00130-6","article-title":"WHO launches global initiative for arboviral diseases.","volume":"3","author":"Balakrishnan","year":"2022","journal-title":"Lancet Microbe"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-020-00257-5","article-title":"Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development.","volume":"5","author":"Bopp","year":"2020","journal-title":"NPJ Vaccines"},{"key":"B3","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41577-018-0004-8","article-title":"C-type lectins in immunity and homeostasis.","volume":"18","author":"Brown","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"B4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s12276-021-00610-1","article-title":"Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy.","volume":"53","author":"Casel","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111736","article-title":"Age is a critical risk factor for severe fever with thrombocytopenia syndrome.","volume":"9","author":"Ding","year":"2014","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1182\/blood-2006-09-048058","article-title":"The DC-SIGN-related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells.","volume":"109","author":"Dominguez-Soto","year":"2007","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1126\/science.1066371","article-title":"Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR.","volume":"294","author":"Feinberg","year":"2001","journal-title":"Science"},{"key":"B8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.virol.2007.11.001","article-title":"Interactions of LSECtin and DC-SIGN\/DC-SIGNR with viral ligands: differential pH dependence, internalization and virion binding.","volume":"373","author":"Gramberg","year":"2008","journal-title":"Virology"},{"key":"B9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nsmb784","article-title":"Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR.","volume":"11","author":"Guo","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084259","article-title":"Bridging the species divide: transgenic mice humanized for type-I interferon response.","volume":"9","author":"Harari","year":"2014","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1128\/JVI.02628-12","article-title":"Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines.","volume":"87","author":"Hofmann","year":"2013","journal-title":"J. Virol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018556","article-title":"High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice.","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3851\/IMP3036","article-title":"Successful treatment of rapidly progressing severe fever with thrombocytopenia syndrome with neurological complications using intravenous immunoglobulin and corticosteroid.","volume":"21","author":"Kim","year":"2016","journal-title":"Antivir. Ther."},{"key":"B14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3904\/kjim.2016.109","article-title":"In vitro antiviral activity of ribavirin against severe fever with thrombocytopenia syndrome virus.","volume":"32","author":"Lee","year":"2017","journal-title":"Korean J. Intern. Med."},{"key":"B15","first-page":"81","article-title":"[Fever with thrombocytopenia associated with a novel bunyavirus in China].","volume":"25","author":"Li","year":"2011","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"B16","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S1473-3099(18)30293-7","article-title":"Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study.","volume":"18","author":"Li","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41422-019-0214-z","article-title":"Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality.","volume":"29","author":"Li","year":"2019","journal-title":"Cell Res."},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2287681","article-title":"An extracellular humanized IFNAR immunocompetent mouse model for analyses of human interferon alpha and subtypes.","volume":"13","author":"Li","year":"2024","journal-title":"Emerg. Microbes Infect."},{"key":"B19","doi-asserted-by":"crossref","first-page":"32035","DOI":"10.1074\/jbc.M402296200","article-title":"C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles.","volume":"279","author":"Lozach","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.chom.2011.06.007","article-title":"DC-SIGN as a receptor for phleboviruses.","volume":"10","author":"Lozach","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1007\/s44231-023-00035-6","article-title":"Research progress of fever with thrombocytopenia syndrome.","author":"Luo","year":"2023","journal-title":"Intensive Care Res."},{"key":"B22","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.3390\/molecules20022229","article-title":"Human lectins and their roles in viral infections.","volume":"20","author":"Mason","year":"2015","journal-title":"Molecules"},{"key":"B23","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/eji.202048793","article-title":"Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway.","volume":"51","author":"Meyts","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"B24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/22221751.2020.1748521","article-title":"Mapping the global potential transmission hotspots for severe fever with thrombocytopenia syndrome by machine learning methods.","volume":"9","author":"Miao","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"B25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jiac.2017.11.004","article-title":"Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndrome.","volume":"24","author":"Nakamura","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"B26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/76872","article-title":"Type 1 IFNs and regulation of TH1 responses: enigmas both resolved and emerge.","volume":"1","author":"O\u2019Shea","year":"2000","journal-title":"Nat. Immunol."},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106079","article-title":"Development and evaluation of a mouse model susceptible to severe fever with thrombocytopenia syndrome virus by rAAV-based exogenous human DC-SIGN expression.","volume":"178","author":"Park","year":"2023","journal-title":"Microb. Pathog."},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.1186\/s42826-020-00070-0","article-title":"Pathogenicity of severe fever with thrombocytopenia syndrome virus in mice regulated in type I interferon signaling: severe fever with thrombocytopenia and type I interferon.","volume":"36","author":"Park","year":"2020","journal-title":"Lab. Anim. Res."},{"key":"B29","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1073\/pnas.051631398","article-title":"DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans.","volume":"98","author":"Pohlmann","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B30","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.4049\/jimmunol.180.10.6836","article-title":"Decreased pathology and prolonged survival of human DC-SIGN transgenic mice during mycobacterial infection.","volume":"180","author":"Schaefer","year":"2008","journal-title":"J. Immunol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00990","article-title":"Mouse DC-SIGN\/CD209a as target for antigen delivery and adaptive immunity.","volume":"9","author":"Schetters","year":"2018","journal-title":"Front. Immunol."},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-015-0412-3","article-title":"Combination effects of ribavirin and interferons on severe fever with thrombocytopenia syndrome virus infection.","volume":"12","author":"Shimojima","year":"2015","journal-title":"Virol. J."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.797189","article-title":"Animal model of severe fever with thrombocytopenia syndrome virus infection.","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Microbiol."},{"key":"B34","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI129171","article-title":"Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections.","volume":"130","author":"Suzuki","year":"2020","journal-title":"J. Clin. Invest."},{"key":"B35","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.cellsig.2010.03.018","article-title":"C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity.","volume":"22","author":"Svajger","year":"2010","journal-title":"Cell Signal."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00150","article-title":"Antiviral drugs against severe fever with thrombocytopenia syndrome virus infection.","volume":"11","author":"Takayama-Ito","year":"2020","journal-title":"Front. Microbiol."},{"key":"B37","first-page":"e00061","article-title":"Efficacy of T-705 (Favipiravir) in the treatment of infections with lethal severe fever with thrombocytopenia syndrome virus.","volume":"1","author":"Tani","year":"","journal-title":"mSphere"},{"key":"B38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.virol.2019.06.014","article-title":"Identification of the amino acid residue important for fusion of severe fever with thrombocytopenia syndrome virus glycoprotein.","volume":"535","author":"Tani","year":"2019","journal-title":"Virology"},{"key":"B39","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1128\/JVI.00110-16","article-title":"Characterization of glycoprotein-mediated entry of severe fever with thrombocytopenia syndrome virus.","volume":"90","author":"Tani","year":"","journal-title":"J. Virol."},{"key":"B40","doi-asserted-by":"crossref","first-page":"109076","DOI":"10.1016\/j.vetmic.2021.109076","article-title":"A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice.","volume":"257","author":"Tian","year":"2021","journal-title":"Vet. Microbiol."},{"key":"B41","doi-asserted-by":"crossref","first-page":"25.06","DOI":"10.4049\/jimmunol.206.Supp.25.06","article-title":"LSECtin (CLEC4G) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling.","volume":"206","author":"Wang","year":"2021","journal-title":"J. Immunol."},{"key":"B42","article-title":"Interferon stimulated immune profile changes in a humanized mouse model of HBV infection.","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"B43","article-title":"2A self-cleaving peptide-based multi-gene expression system in the silkworm Bombyx mori.","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009587","article-title":"Infection of humanized mice with a novel phlebovirus presented pathogenic features of severe fever with thrombocytopenia syndrome.","volume":"17","author":"Xu","year":"2021","journal-title":"PLoS Pathog."},{"key":"B45","doi-asserted-by":"crossref","first-page":"e02246","DOI":"10.1128\/JVI.02246-17","article-title":"RIG-I-like receptor and toll-like receptor signaling pathways cause aberrant production of inflammatory cytokines\/chemokines in a severe fever with thrombocytopenia syndrome virus infection mouse model.","volume":"92","author":"Yamada","year":"2018","journal-title":"J. Virol."},{"key":"B46","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2022.5174","article-title":"Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (Review).","volume":"50","author":"Yang","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"B47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/08830185.2013.834897","article-title":"DC-SIGN, DC-SIGNR and LSECtin: C-type lectins for infection.","volume":"33","author":"Zhang","year":"2014","journal-title":"Int. Rev. Immunol."},{"key":"B48","article-title":"CCR2 is a host entry receptor for severe fever with thrombocytopenia syndrome virus.","volume":"9","author":"Zhang","year":"2023","journal-title":"Sci. Adv."},{"key":"B49","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s40121-022-00693-x","article-title":"Antiviral treatment options for severe fever with thrombocytopenia syndrome infections.","volume":"11","author":"Zhang","year":"2022","journal-title":"Infect. Dis. Ther."},{"key":"B50","first-page":"433","article-title":"Differences in innate immune response between man and mouse.","volume":"34","author":"Zschaler","year":"2014","journal-title":"Crit. Rev. Immunol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1452739\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T06:26:13Z","timestamp":1734589573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1452739\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":50,"alternative-id":["10.3389\/fmicb.2024.1452739"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1452739","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"article-number":"1452739"}}